HK195495A - Novel thf compositions - Google Patents

Novel thf compositions

Info

Publication number
HK195495A
HK195495A HK195495A HK195495A HK195495A HK 195495 A HK195495 A HK 195495A HK 195495 A HK195495 A HK 195495A HK 195495 A HK195495 A HK 195495A HK 195495 A HK195495 A HK 195495A
Authority
HK
Hong Kong
Prior art keywords
leu
peptide
amino acid
thf
pro
Prior art date
Application number
HK195495A
Other languages
German (de)
English (en)
French (fr)
Inventor
Trainin Nathan
Burstein Yigal
Original Assignee
Yeda Research & Development Company, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research & Development Company, Ltd. filed Critical Yeda Research & Development Company, Ltd.
Publication of HK195495A publication Critical patent/HK195495A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/065—Thymic humoral factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/18—Thymus derived hormone or factor; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK195495A 1985-06-06 1995-12-28 Novel thf compositions HK195495A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/741,753 US4621135A (en) 1983-12-08 1985-06-06 Novel THF compositions

Publications (1)

Publication Number Publication Date
HK195495A true HK195495A (en) 1996-01-05

Family

ID=24982034

Family Applications (1)

Application Number Title Priority Date Filing Date
HK195495A HK195495A (en) 1985-06-06 1995-12-28 Novel thf compositions

Country Status (16)

Country Link
US (1) US4621135A (OSRAM)
EP (1) EP0204328B1 (OSRAM)
JP (2) JPS6248698A (OSRAM)
KR (1) KR900003095B1 (OSRAM)
AT (1) ATE110389T1 (OSRAM)
AU (1) AU569193B2 (OSRAM)
CA (1) CA1270597A (OSRAM)
CZ (1) CZ419491A3 (OSRAM)
DE (2) DE3650035T2 (OSRAM)
DK (1) DK262986A (OSRAM)
ES (6) ES8801322A1 (OSRAM)
HK (1) HK195495A (OSRAM)
IL (1) IL78951A (OSRAM)
NZ (1) NZ216316A (OSRAM)
SK (1) SK419491A3 (OSRAM)
ZA (1) ZA863848B (OSRAM)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807830A (en) * 1987-12-30 1998-09-15 Cytoven J.V. Method for treatment of purulent inflammatory diseases
US5728680A (en) 1987-12-30 1998-03-17 Cytoven J.V. Methods for normalizing numbers of lymphocytes
US5811399A (en) * 1988-12-14 1998-09-22 Cytran, Inc. Pharmaceutical dipeptide compositions and methods of use thereof: immunodepressants
US5770576A (en) * 1989-08-30 1998-06-23 Cytran, Inc. Pharmaceutical dipeptide compositions and methods of use thereof: systemic toxicity
US6066622A (en) * 1991-10-28 2000-05-23 Cytran, Inc. Immunomodulating peptides and methods of use
US6100380A (en) * 1991-10-28 2000-08-08 Cytran, Inc. Immunomodulating peptides and methods of use
IL106214A (en) * 1993-07-01 1998-12-06 Yeda Res & Dev Thf-gamma2 analogs and pharmaceutical compositions comprising them
MX339762B (es) 2011-09-28 2016-05-27 Univ Autonoma Del Estado De Morelos Metalopeptidos inmunomoduladores (immp) y composiciones que los contienen.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4881838A (OSRAM) * 1972-02-15 1973-11-01
US4002602A (en) * 1974-03-11 1977-01-11 Gideon Goldstein Ubiquitous immunopoietic polypeptide (UBIP) and methods
NL7502830A (nl) * 1974-03-25 1975-09-29 Jean Francois Bach En Dr Jean Werkwijze voor het isoleren van een polypeptide hormoon.
IL47645A (en) * 1975-07-04 1980-10-26 Yeda Res & Dev Substantially pure and uniform thymic hormone thf,its preparation and pharmaceutical compositions containing it
DE2732587A1 (de) * 1976-09-22 1978-03-23 Bach Jean Francois Polypeptid mit thymischer wirksamkeit
US4079127A (en) * 1976-10-28 1978-03-14 Board Of Regents Of The University Of Texas Thymosin alpha 1
US4275153A (en) * 1978-08-03 1981-06-23 American Hospital Supply Corporation Analytical fluorogenic substrates for proteolytic enzymes
SE448605B (sv) * 1980-10-27 1987-03-09 Vtoroi Mo G Med I Imen Terapeutiskt preparat for reglering av t-immunsystemet och forfarande for framstellning derav
US4374828A (en) * 1980-11-17 1983-02-22 Board Of Reagents, The University Of Texas System Biologically active thymones from the thymus
IT1148005B (it) * 1981-04-09 1986-11-26 Leonida Grippa Tripeptide nelle sue sei combinazioni amminoacide alania fenilalanina e leucina in particolare fenil-alanina-alanina-leucina (p-a-l) aventela proprieta' di esaltare l'immunita' antivirale ed antitumorale
US4505898A (en) * 1982-04-21 1985-03-19 Marks Robert E Derivatives of acetylsalicylic acid and substituted phenylacetic acids and compositions containing them

Also Published As

Publication number Publication date
US4621135A (en) 1986-11-04
IL78951A0 (en) 1986-09-30
SK419491A3 (en) 1995-07-11
DK262986A (da) 1986-12-07
ES555737A0 (es) 1987-12-16
DE3650035D1 (de) 1994-09-29
DK262986D0 (da) 1986-06-04
ES8801322A1 (es) 1987-12-16
AU5833686A (en) 1987-01-08
ES557740A0 (es) 1987-12-16
JPH01156997A (ja) 1989-06-20
JPH0210160B2 (OSRAM) 1990-03-06
ES557736A0 (es) 1987-12-16
ES557739A0 (es) 1988-01-01
DE204328T1 (de) 1987-11-05
ES8801307A1 (es) 1987-12-16
NZ216316A (en) 1991-11-26
ES8801317A1 (es) 1988-01-01
ES8801308A1 (es) 1987-12-16
ZA863848B (en) 1987-12-30
ES8801316A1 (es) 1987-12-16
EP0204328A3 (en) 1988-07-27
EP0204328B1 (en) 1994-08-24
CA1270597A (en) 1990-06-19
ES8801315A1 (es) 1987-12-16
IL78951A (en) 1990-11-05
JPS6248698A (ja) 1987-03-03
KR870000357A (ko) 1987-02-18
ES557738A0 (es) 1987-12-16
ATE110389T1 (de) 1994-09-15
AU569193B2 (en) 1988-01-21
DE3650035T2 (de) 1995-03-23
KR900003095B1 (ko) 1990-05-07
JPH0422919B2 (OSRAM) 1992-04-20
EP0204328A2 (en) 1986-12-10
ES557737A0 (es) 1987-12-16
CZ419491A3 (en) 1993-03-17

Similar Documents

Publication Publication Date Title
Ling et al. Isolation, primary structure, and synthesis of human hypothalamic somatocrinin: growth hormone-releasing factor.
JP4001604B2 (ja) 新規蛋白質及びこれを使用した薬剤の製法
EP0100641B1 (en) Human lymphotoxin and derivatives thereof, process for its preparation, and pharmaceutical composition containing it
JPH03504013A (ja) Ｔ細胞ヘルパー活性を有するペプチド
van der Rest et al. A comprehensive approach to the study of collagen primary structure based on high‐performance liquid chromatography
Edmundson et al. Isolation and characterization of concanavalin A polypeptide chains
EP0204328B1 (en) Novel THF compositions
Rosenstreich et al. A human urine-derived interleukin 1 inhibitor. Homology with deoxyribonuclease I.
EP0138616A2 (en) Nona- and dodecapeptides for augmenting natural killer cell activity, processes for making them and pharmaceutical compositions comprising them
Low et al. Solid-phase synthesis of thymosin. beta. 4: chemical and biological characterization of the synthetic peptide
Albericio et al. Convergent solid phase peptide synthesis. v. synthesis of the 1-4, 32-34, and 53-59 protected segments of the toxin ii of androctonus australis hector.
Abiko et al. Identification and synthesis of a tripeptide in ECUM fluid of an upemic patient
SCHWARTZ et al. [12‐ASPARAGINE‐B] HUMAN INSULIN: An Analogue with Modification in the Hydrophobic Core of Insulin
Mihara et al. Synthesis of the 60 amino acid homeo domain and smaller fragments of the Drosophila gene regulatory protein Antennapedia by a segment synthesis-condensation approach
Wong et al. Synthesis of a fully active snake venom cardiotoxin by fragment condensation on solid polymer
Hashim et al. Experimental allergic encephalomyelitis: Basic protein regions responsible for delayed hypersensitivity
TZOUGRAKI et al. SYNTHESIS OF HUMAN β‐ENDORPHIN IN SOLUTION USING BENZYL‐TYPE SIDE CHAIN PROTECTIVE GROUPS
US11419919B1 (en) High-purity adrenocorticotropic hormone, analogue and a large-scale preparation method thereof
Yaron et al. Synthesis and immunological properties of the oligolysyl-Niε-dinitrophenyllysine and oligolysylalanylalanylalanyl-Niε-dinitrophenyllysine peptide series
ABIKO et al. The effect of a synthetic thymosin α1 fragment on the inhibition of E-rosette formation by the serum of a patient with nephrotic syndrome
Lundblad Isolation of fucose-rich glycopeptides from normal urine
Delmas et al. Solid phase synthesis of two cholera toxin B subunit antigens
Knight et al. Solvent systems for the countercurrent chromatography of hydrophobic neuropeptide analogs and hydrophilic protein fragments
Sloane et al. Studies on an antineoplastic fraction from human urine. Characterization of the major protein in this fraction
US4370312A (en) Decapeptide

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)